Lipoxygenase-mediated secretory effect of canatoxin the toxic protein from Canavalia ensiformis seeds

Barja-Fidalgo, 1988, The secretory effect of canatoxin on rat brain synaptosomes involves a lipoxygenase-mediated pathway, Braz. J. Med. Biol. Res., 21, 549 Carlini, 1981, Isolation and characterization of a toxic protein from Canavalia ensiformis (jack beans) seeds, distinct from concanavalin A, Toxicon, 19, 667, 10.1016/0041-0101(81)90104-5 Carlini, 1984, Central nervous effect of the convulsant protein canatoxin, Acta pharmacol, Tox., 54, 161, 10.1111/j.1600-0773.1984.tb01912.x Carlini, 1985, Platelet release reaction and aggregation induced by canatoxin, a convulsant protein: evidence for the involvement of the platelet lipoxygenase pathway, Br. J. Pharmacol., 84, 551, 10.1111/j.1476-5381.1985.tb12940.x Collares, 1988, Involvement of lipoxygenase and cyclo-oxygenase pathways in hypoxia and metabolic alkalosis produced by canatoxin in rats, Braz. J. Med. Biol. Res., 21, 107 DaPrada, 1988, Platelets as model for neurons?, Experientia, 44, 115, 10.1007/BF01952193 Jones, 1987, Adrenal synthesis of corticosterone in response to ACTH in rats influenced by leukotriene B4 and by lipoxygenases intermediates, J. Endocrinol., 112, 253, 10.1677/joe.0.1120253 McDaniel, 1983, A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans, Methods Enzymol., 98, 182, 10.1016/0076-6879(83)98149-1 Metz, 1985, Glucose increases the synthesis of lipoxygenase-mediated metabolites of arachidonic acid in intact rat islets, 82, 198 Metz, 1986, Ether-linked lysophospholipids initiate insulin secretion, Diabetes, 35, 808, 10.2337/diabetes.35.7.808 Metz, 1983, Lipoxygenase pathway in islets endocrine cells, J. Clin. Invest., 71, 1191, 10.1172/JCI110868 Nadler, 1987, Specific action of the lipoxygenase pathway in mediating angiotensin II-induced aldosterone synthesis in isolated adrenal glomerular cells, J. Clin. Invest., 80, 1763, 10.1172/JCI113269 Naor, 1985, Mechanism of action of gonadotropin-releasing hormone: role of lipoxygenase products of arachidonic acid in luteinizing hormone release, J. Steroid Biochem., 23, 711, 10.1016/S0022-4731(85)80006-6 Peters, 1981, Lipoxygenase products modulate histamine release in human basophils, Nature, 292, 455, 10.1038/292455a0 Piomelli, 1987, Lipoxygenase metabolities of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells, Nature, 328, 38, 10.1038/328038a0 Pletscher, 1988, Platelets as models: use and limitations, Experientia, 44, 152, 10.1007/BF01952200 Ribeiro-Dasilva, 1989, Hypoglycemia and lipoxygenase-dependent insulin secretion produced in rats by canatoxin, Toxicon, 27, 73, 10.1016/0041-0101(89)90364-4 Ribeiro-Dasilva, 1989, Effects of canatoxin on the circulating levels of gonadotropins and prolactin in rats, Braz. J. Med. Biol. Res., 22, 387 Ribeiro-Dasilva, 1989, Convulsions induced by canatoxin in rats are probably a consequence of hypoxia, Braz. J. Med. Biol. Res., 22, 877 Sekyia, 1982, Selective inhibition of platelet lipoxygenase by esculetin, Biochim. biophys, Acta, 613, 68 Snider, 1984, Neurotransmitter receptors mediated cyclic GMP formation by involvement of arachidonic acid and lipoxygenase, 81, 3905 Spector, 1989, HETEs, Prog. Lip. Res., 27, 271, 10.1016/0163-7827(88)90009-4 Turk, 1987, The role of phospholipid-derived mediators including arachidonic acid, its metabolites and inositol triphosphate and of intracellular Ca2+ in glucose-induced insulin secretion by pancreatic islets, Prog. Lip. Res., 26, 125, 10.1016/0163-7827(87)90010-5 Yamamoto, 1985, Lipoxygenase inhibitors and cyclic AMP-mediated insulin secretion caused by forskolin, theophilline and dibutyryl cyclic AMP, J. Pharmac. exp. Ther., 233, 176